|
(Click here for meetings with SEC officials)
|
| May 26, 2020 | Andy Green, Managing Director of Economic Policy, Center for American Progress, et al |
| Aug. 22, 2019 | Kurt N. Schacht, JD. CFA, Managing Director, Advocacy, and Sandra J. Peters, CPA, CFA, Head, Global Financial Reporting Policy; CFA Institute |
| Aug. 16, 2019 | Dorsey & Whitney LLP |
| Aug. 13, 2019 | Charles Crain, Director, Tax and Domestic Economic Policy, National Association of Manufacturers |
| Aug. 13, 2019 | Mike Raab, President and CEO, Ardelyx, Inc. |
| Jul. 29, 2019 | Louis Arcudi, Chief Financial Officer, and Jennifer Minai, VP, Finance, Millendo Therapeutics, Inc. |
| Jul. 29, 2019 | Crowe LLP |
| Jul. 29, 2019 | Christopher Iacovella, Chief Executive Officer, American Securities Association |
| Jul. 29, 2019 | Tom Quaadman, Executive Vice President, Center for Capital Markets Competitiveness, US Chamber of Commerce |
| Jul. 29, 2019 | RSM US LLP |
| Jul. 29, 2019 | Cameron Arterton, Vice President, Biotechnology Innovation Organization |
| Jul. 29, 2019 | BDO USA, LLP |
| Jul. 29, 2019 | Julie Bell Lindsay, Executive Director, Center for Audit Quality |
| Jul. 29, 2019 | Dennis M. Kellher, President & CEO, and Lev Bagramian, Senior Securities Policy Advisor, Better Markets, Inc. |
| Jul. 29, 2019 | KPMG LLP |
| Jul. 29, 2019 | Joseph L. Schocken, President & CEO, Broadmark Capital |
| Jul. 29, 2019 | John A. Zecca, Senior Vice President, General Counsel North America, Nasdaq, Inc. |
| Jul. 29, 2019 | Ernst & Young LLP |
| Jul. 29, 2019 | Faisal Shawwa, Executive Director, Finance, Catalyst Biosciences, Inc. |
| Jul. 29, 2019 | Barbara Roper, Director of Investor Protection, Consumer Federation of America |
| Jul. 26, 2019 | Eugene H. Walpole, Executive Vice President & CFO, The Bank of South Carolina |
| Jul. 26, 2019 | Ashley W. Wittorf, Executive Director, AdvaMed Accel |
| Jul. 26, 2019 | A. O'Neil Rashley, Senior Vice President and Counsel, South Carolina Bankers Association |
| Jul. 26, 2019 | Deloitte & Touche LLP |
| Jul. 26, 2019 | Weili Ge, Moss Adams Endowed Professor in Accounting, University of Washington; Allison Koester, Saleh Romeih Associate Professor in Accounting, Georgetown University; and Sarah McVay, Deloitte & Touche Endowed Professor in Accounting, University of Washington |
| Jul. 26, 2019 | Proskauer Rose LLP |
| Jul. 26, 2019 | Chris Netram, Vice President, Tax & Domestic Economic Policy, National Association of Manufacturers |
| Jul. 26, 2019 | Paula J. Meiler, Senior Vice President, Chief Financial Officer, CSB Bancorp, Inc. |
| Jul. 25, 2019 | PricewaterhouseCoopers LLP |
| Jul. 25, 2019 | Jeffrey P. Mahoney, General Counsel, Council of Institutional Investors |
| Jul. 25, 2019 | Council of State Bioscience Associations |
| Jul. 24, 2019 | Daniel Menold, Vice President of Finance, CymaBay Therapeutics, Inc. |
| Jul. 24, 2019 | Andrew Allen, CEO, Gritstone Oncology Inc. |
| Jul. 24, 2019 | Christpher Cole, Executive Vice President and Senior Regulatory Counsel, Independent Community Bankers of America |
| Jul. 24, 2019 | Advanced Medical Technology Association, et al. |
| Jul. 23, 2019 | Shaun A. Burke, President and Chief Executive Officer, Guaranty Federal Bancshares, Inc. |
| Jul. 23, 2019 | Janice L. Gray, Chair, and Ken L. Bishop, President and CEO, National Association of State Boards of Accountancy |
| Jul. 23, 2019 | Damian Finio, Chief Financial Officer, Teligent Inc. |
| Jul. 22, 2019 | Jason Keyes, Chief Financial Officer, Equillium, Inc. |
| Jul. 22, 2019 | Tobin C. Schilke, CFO, Revance Therapeutics Inc |
| Jul. 22, 2019 | Colleen Honigsberg, Associate Professor of Law, Stanford Law School, et al. |
| Jul. 22, 2019 | Joseph Ferra, Chief Financial Officer, Syros Pharmaceuticals, Inc. |
| Jul. 19, 2019 | Alfred G. Merriweather, Chief Executive Officer, Adamas Pharmaceuticals, Inc. |
| Jul. 19, 2019 | Leiv Lea, Chief Financial Officer, Corvus Pharmaceuticals |
| Jul. 19, 2019 | Michael A. Pisetsky, General Counsel, SI-BONE, Inc. |
| Jul. 19, 2019 | Michael A. Shriner, President/CEO, MSB Financial Corp |
| Jul. 18, 2019 | Mark Kaufmann, Chief Financial Officer, Ardelyx, Inc. |
| Jul. 18, 2019 | Taylor Crouch, Chief Executive Officer, Organovo, Inc. |
| Jul. 18, 2019 | Marilyn J. Bruno, CEO, Aequor, inc. |
| Jul. 17, 2019 | David Vandertie, Vice President, Finance, Evoke Pharma, Inc. |
| Jul. 17, 2019 | Marc Belsky, Chief Financial Officer, Kezar Life Sciences |
| Jul. 17, 2019 | Michael McNamara, Director of Finance and Controller, Marinus Pharmaceuticals Inc |
| Jul. 17, 2019 | Grant Thornton LLP |
| Jul. 16, 2019 | Nancy J. Schroeder, CPA, Chair, Financial Reporting Committee, and Heather Bain, CPA, MBA, CMA, Chair, Small Business Committee; Institute of Management Accountants |
| Jul. 11, 2019 | Mark J. Fitzpatrick, President, Chiasma, Inc. |
| Jul. 11, 2019 | Mary Barth, Professor, Stanford Graduate School of Business; Wayne Landsman, Professor, Kenan-Flagler Business School; Joseph Schroeder, Professor, Kelley School of Business; and Daniel Taylor, Professor, The Wharton School |
| Jul. 11, 2019 | Ahmed S. Mousa, General Counsel, Pieris Pharmaceuticals |
| Jul. 10, 2019 | Lisa Walters-Hoffert, Chief Financial Officer, Dare Bioscience, Inc. |
| Jul. 8, 2019 | William J. Newell, Chief Executive Officer, Sutro Biopharma, Inc. |
| Jul. 8, 2019 | James E. Fickenscher, CFO and VP, Corporate Development, Zynerba Pharmaceuticals, Inc. |
| Jul. 3, 2019 | Chris Sullivan, Corporate Controller, Cerecor |
| Jul. 1, 2019 | Ryan J. Lynch, Corporate Controller, Concert Pharmaceuticals, Inc. |
| Jun. 19, 2019 | Ian Mortimer, President and Chief Financial Officer, Xenon Pharmaceuticals Inc. |
| Jun. 10, 2019 | Jennifer Nieto, Vice President, Federal Government Relations and Alliance Development, California Life Sciences Association |
| Jun. 5, 2019 | Darian B. Andersen, General Counsel, P.C. |
| May 29, 2019 | Michael James, Chief Financial Officer, and Megan Jimenez, Controller; Terra Tech Corp |
| May 28, 2019 | James Brush, President and CEO, Summit State Bank |
| May 25, 2019 | Kyle Carver |
| May 19, 2019 | John Hassell, Professor of Accounting, Indiana University |
Meetings with SEC Officials
(Click here for submitted comments from the public)
|
| Aug. 27, 2019 | Memorandum from the Office of Commissioner Allison Herren Lee regarding an August 20, 2019, meeting with representatives of Better Markets |
| Jul. 26, 2019 | Memorandum from the Division of Economic and Risk Analysis regarding a July 9, 2019, telephone conversation with Daniel Taylor and Joseph Schroeder |
